Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response
NCT03300518Completed
- Sponsor
- Reproductive and Genetic Hospital of CITIC-Xiangya
- Start
- Nov 2017
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of estradiol valerate in infertility (2 arms), sponsored by Reproductive and Genetic Hospital of CITIC-Xiangya. Primary endpoint: The number of oocytes retrieved by the IVG 36 hours after hCG administration. Started Nov 2017; status: completed.
02
Drugs
estradiol valerate
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03300518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03300518.